Comparison between Mono Pharmacare IPO and Sungarner Energies IPO.
Mono Pharmacare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sungarner Energies IPO is a SME Fixed Price proposed to list at NSE SME.
| Mono Pharmacare IPO | Sungarner Energies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Unistone Capital Pvt.Ltd. | Novus Capital Advisors Private Limited |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mono Pharmacare IPO is up to ₹14.07 Cr whereas the issue size of the Sungarner Energies IPO is up to ₹4.83 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Sungarner Energies IPO is ₹83.00 per share.
| Mono Pharmacare IPO | Sungarner Energies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹26.00 per share | |
| Issue Price (Upper) | ₹28.00 per share | |
| Issue Price (Final) | ₹28.00 per share | ₹83.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 1600 shares |
| Fresh Issue Size | 50,24,000 shares | 5,82,400 shares |
| Fresh Issue Size (Amount) | up to ₹14.07 Cr | up to ₹4.83 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 50,24,000 shares | 5,82,400 shares |
| Issue Size Total (Amount) | up to ₹14.07 Cr | up to ₹4.83 Cr |
Mono Pharmacare IPO opens on Aug 28, 2023, while Sungarner Energies IPO opens on Aug 21, 2023. The closing date of Mono Pharmacare IPO and Sungarner Energies IPO is Aug 30, 2023, and Aug 23, 2023, respectively.
| Mono Pharmacare IPO | Sungarner Energies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 28, 2023 | Aug 21, 2023 |
| Issue Close | Aug 30, 2023 | Aug 23, 2023 |
| Basis Of Allotment (Tentative) | Sep 04, 2023 | Aug 28, 2023 |
| Initiation of Refunds (Tentative) | Sep 05, 2023 | Aug 29, 2023 |
| Credit of Share (Tentative) | Sep 06, 2023 | Aug 30, 2023 |
| Listing date (Tentative) | Sep 07, 2023 | Aug 31, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mono Pharmacare IPO P/E ratio is , as compared to Sungarner Energies IPO P/E ratio of 13.07.
| Mono Pharmacare IPO | Sungarner Energies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.02 | 84.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.49 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹49.47 Cr. | ₹19.25 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 9.01% | 31.17% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.34% | 25.28% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.92 | 1.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.99 | ₹6.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 9.01% | 23.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mono Pharmacare IPO Retail Individual Investors (RII) are offered 22,64,000 shares while in Sungarner Energies IPO retail investors are offered 22,64,000 shares. Qualified Institutional Buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and in Sungarner Energies IPO.
| Mono Pharmacare IPO | Sungarner Energies IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,76,000 shares | 57,600 shares |
| QIB | 5,00,000 shares | |
| NII | 22,60,000 shares | 2,91,200 shares |
| RII | 22,64,000 shares | 2,91,200 shares |
| Employee | ||
| Others | ||
| Total | 50,24,000 shares | 5,82,400 shares |
Mono Pharmacare IPO subscribed 13.42x in total, whereas Sungarner Energies IPO subscribed 152.40x.
| Mono Pharmacare IPO | Sungarner Energies IPO | |
|---|---|---|
| QIB (times) | 10.89x | |
| NII (times) | 8.00x | 110.59x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 19.40x | 192.93x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 13.42x | 152.40x |
